Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Plos Medicine
|
June 14, 2006
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology
Thomas G Smith, Jerome T Brooks, George M Balanos, et al.
The Journal of Clinical Investigation
|
January 31, 2020
Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control
Xiaotong Cheng, Maria Prange-Barczynska, James W Fielding, et al.
Plos One
|
July 7, 2015
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
Mun Chiang Chan, Onur Atasoylu, Emma Hodson, et al.
The Journal of Clinical Investigation
|
February 15, 2011
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
Sarah R Walmsley, Edwin R Chilvers, Alfred A Thompson, et al.
ACS Chemical Biology
|
May 21, 2013
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases
Rasheduzzaman Chowdhury, José Ignacio Candela-Lena, Mun Chiang Chan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 11, 2011
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation
Federico Formenti, Philip A Beer, Quentin P P Croft, et al.
Chemical Science
|
February 14, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Tzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, et al.
Molecular and Cellular Biology
|
March 12, 2008
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
Tammie Bishop, Denis Gallagher, Alberto Pascual, et al.
The Journal of Pathology
|
June 2, 2011
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella, Mona El-Bahrawy, Norma Frizzell, et al.
Cell Reports
|
September 28, 2017
Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive Diabetes
Julie Adam, Reshma Ramracheya, Margarita V Chibalina, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Plos Medicine
|
June 14, 2006
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology
Thomas G Smith, Jerome T Brooks, George M Balanos, et al.
The Journal of Clinical Investigation
|
January 31, 2020
Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control
Xiaotong Cheng, Maria Prange-Barczynska, James W Fielding, et al.
Plos One
|
July 7, 2015
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
Mun Chiang Chan, Onur Atasoylu, Emma Hodson, et al.
The Journal of Clinical Investigation
|
February 15, 2011
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
Sarah R Walmsley, Edwin R Chilvers, Alfred A Thompson, et al.
ACS Chemical Biology
|
May 21, 2013
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases
Rasheduzzaman Chowdhury, José Ignacio Candela-Lena, Mun Chiang Chan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 11, 2011
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation
Federico Formenti, Philip A Beer, Quentin P P Croft, et al.
Chemical Science
|
February 14, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Tzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, et al.
Molecular and Cellular Biology
|
March 12, 2008
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
Tammie Bishop, Denis Gallagher, Alberto Pascual, et al.
The Journal of Pathology
|
June 2, 2011
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella, Mona El-Bahrawy, Norma Frizzell, et al.
Cell Reports
|
September 28, 2017
Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive Diabetes
Julie Adam, Reshma Ramracheya, Margarita V Chibalina, et al.
Page
of 7